Page 19 - Smab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How to Know If You're Maximizing Your mAb Recovery High concentration mAb formulations and their properties Image credit: Pall Corporation Having first emerged as therapeutics in the 1980s, monoclonal antibodies (mAbs) are the predominant class of recombinant biologic drugs in development. While intravenous (IV) infusion is a frequently utilized administration route for mAbs, for patients requiring a frequent dosing regimen, subcutaneous delivery (sub-C) in doses between 1-1.5 mL is now preferred as it supplies the possibility of self-treatment by utilizing pre-filled syringes 2. mAbs are usu...

Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19 March 10, 2021 20:22 ET | Source: Vir Biotechnology, Inc. Vir Biotechnology, Inc. San Francisco, California, UNITED STATES – Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or death – – Vir and GSK plan to immediately seek Emergency Use Authorization in the U.S. and authorizations in other countries – – Additional new in vitro studi...

22 February 2021 | 07:08am StockMarketWire.com - Pub group Mitchells & Butlers, while launching a planned £350 million equity raising, said its sales had fallen sharply due to the UK's Covid-19 lockdown. Managed sales between 27 September and 16 January had dropped 70% year-on-year, the company said. On a like-for-like basis -- for sites when open, excluding periods of closure -- trading was down 30%. Mitchells & Butlers said none of its sites had been open since the government announced fresh lockdown measures on 30 December. The company had a cash balance of £113 million at 16 January wit...

22 February 2021 | 16:38pm StockMarketWire.com - Details of the UK's reopening plan helped give the FTSE 100 a lift on Monday afternoon with the index recovering earlier heavier losses to trade down just 0.18% at 6,612.24. Hospitality, retail and travel stocks all rallied with pubs group JD Wetherspoon up 8.7% to £13.43, budget airline Jet2 rising 7.2% to £13.14 and WH Smith gaining 6% to £17.85. By 4.30pm UK time the S&P 500 was down 0.6% to 3,884.42. Security group G4S slumped 9.8% to 242.6p after private equity firm GardaWorld said it wouldn't raise its 235p offer for the company, cooli...

22 February 2021 | 08:36am StockMarketWire.com - UK stocks opened lower on Monday as rising US bond yields and inflation fears tempered Covid vaccine optimism. At 0824, the benchmark FTSE 100 index was down 56.45 points, or 0.9%, at 6,567.57. Security group G4S slumped 9.7% to 242.8p after private equity firm GardaWorld said it wouldn't raise its 235p offer for the company, cooling hopes of a bidding war. G4S had rejected GardaWorld's offer in favour of 245p bid from Allied Universal. Pharmaceutical giant AstraZeneca added 0.2% to £72.39 even after it said it was withdrawing a bladder cancer...